REFRACTORY B-CELL LYMPHOMA
Clinical trials for REFRACTORY B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for REFRACTORY B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Gene-Modified immune cells offer hope for tough lymphoma
Disease control Recruiting nowThis study tests a new treatment called TranspoCART19 for people with B-cell lymphoma that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, which are modified in a lab to better recognize and attack cancer cells. The main goals …
Matched conditions: REFRACTORY B-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Disease control
Last updated May 25, 2026 02:18 UTC
-
New study tracks CAR-T's impact on Seniors' daily lives
Knowledge-focused Recruiting nowThis study watches how older patients (age 60 and up) with certain blood cancers handle standard CAR-T cell therapy and how it changes their daily life and thinking skills. No extra treatment is given—just careful checkups. The goal is to see if patients can complete all planned …
Matched conditions: REFRACTORY B-CELL LYMPHOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC